Financial Ratios | Acutaas Chemicals Ltd. | R Wadiwala Securities Pvt Ltd

ACUTAAS CHEMICALS LTD.

NSE : ACUTAASBSE : 543349ISIN CODE : INE00FF01025Industry : Pharmaceuticals & DrugsHouse : Private
BSE1664.75-1.65 (-0.1 %)
PREV CLOSE (Rs.) 1666.40
OPEN PRICE (Rs.) 1652.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9481
TODAY'S LOW / HIGH (Rs.)1646.65 1674.00
52 WK LOW / HIGH (Rs.)919.63 1901.35
NSE1664.004.5 (+0.27 %)
PREV CLOSE( Rs. ) 1659.50
OPEN PRICE (Rs.) 1667.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1664.00 (4)
VOLUME 145992
TODAY'S LOW / HIGH(Rs.) 1642.50 1674.00
52 WK LOW / HIGH (Rs.)918.77 1902

Financial Ratios

Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)19.3911.6022.8619.7517.14
   CEPS(Rs)11.428.7813.1211.263.08
   DPS(Rs)1.503.003.003.000.00
   Book NAV/Share(Rs)159.95182.13163.01143.3451.03
   Tax Rate(%)25.7940.5325.7521.3324.72
Margin Ratios
   Core EBITDA Margin(%)23.0517.9119.8820.2223.53
   EBIT Margin(%)22.0912.2418.5818.8122.71
   Pre Tax Margin(%)21.4711.4218.1917.5821.06
   PAT Margin (%)15.936.7913.5013.8315.85
   Cash Profit Margin (%)18.589.0315.5115.7717.08
Performance Ratios
   ROA(%)12.135.2311.6813.4216.74
   ROE(%)16.197.7014.9221.0740.51
   ROCE(%)20.1411.8120.4523.8533.43
   Asset Turnover(x)0.760.770.870.971.06
   Sales/Fixed Asset(x)1.781.842.332.402.27
   Working Capital/Sales(x)1.713.452.101.736.79
Efficiency Ratios
   Fixed Capital/Sales(x)0.560.540.430.420.44
   Receivable days90.06111.06116.5899.7994.89
   Inventory Days61.0270.1868.4660.5460.39
   Payable days96.06122.64143.66135.92138.36
Valuation Parameters
   PER(x)62.9747.1819.4450.630.00
   PCE(x)106.8762.3233.8744.410.00
   Price/Book(x)15.266.015.456.970.00
   Yield(%)0.060.270.340.30
   EV/Net Sales(x)19.615.855.166.810.49
   EV/Core EBITDA(x)79.3130.8825.0932.832.03
   EV/EBIT(x)88.8047.8127.7936.212.14
   EV/CE(x)14.994.715.336.770.56
   M Cap / Sales19.855.635.257.000.00
Growth Ratio
   Net Sales Growth(%)40.3416.3318.5752.7142.13
   Core EBITDA Growth(%)83.127.1317.5932.3985.90
   EBIT Growth(%)153.16-23.3417.0926.5291.73
   PAT Growth(%)229.35-41.5215.7733.2496.57
   EPS Growth(%)67.16-49.2615.7715.18-34.48
Financial Stability Ratios
   Total Debt/Equity(x)0.010.320.010.000.85
   Current Ratio(x)3.911.732.813.321.30
   Quick Ratio(x)3.021.182.082.450.94
   Interest Cover(x)35.7614.7947.5015.2713.77
   Total Debt/Mcap(x)0.000.050.000.00